Okumura K - Search Results

1

Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity.

Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H. Nakayama M, et al. Among authors: okumura k. J Exp Med. 2000 Nov 6;192(9):1373-80. doi: 10.1084/jem.192.9.1373. J Exp Med. 2000. PMID: 11067885 Free PMC article.

2

Multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H. Nakayama M, et al. Among authors: okumura k. J Immunol. 2002 Jan 15;168(2):734-43. doi: 10.4049/jimmunol.168.2.734. J Immunol. 2002. PMID: 11777967

3

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Takeda K, et al. Among authors: okumura k. J Exp Med. 2002 Jan 21;195(2):161-9. doi: 10.1084/jem.20011171. J Exp Med. 2002. PMID: 11805143 Free PMC article.

4

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.

Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K. Harada N, et al. Among authors: okumura k. Biochem Biophys Res Commun. 2002 Dec 6;299(3):488-93. doi: 10.1016/s0006-291x(02)02670-0. Biochem Biophys Res Commun. 2002. PMID: 12445828

5

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H. Nakayama M, et al. Among authors: okumura k. J Immunol. 2003 Jan 1;170(1):341-8. doi: 10.4049/jimmunol.170.1.341. J Immunol. 2003. PMID: 12496418

6

Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL).

Kayagaki N, Yamaguchi N, Abe M, Hirose S, Shirai T, Okumura K, Yagita H. Kayagaki N, et al. Among authors: okumura k. Cell Immunol. 2002 Oct;219(2):82-91. doi: 10.1016/s0008-8749(02)00602-0. Cell Immunol. 2002. PMID: 12576026

7

Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies.

Nakayama M, Harada N, Okumura K, Yagita H. Nakayama M, et al. Among authors: okumura k. Biochem Biophys Res Commun. 2003 Jul 11;306(4):819-25. doi: 10.1016/s0006-291x(03)01051-9. Biochem Biophys Res Commun. 2003. PMID: 12821115

8

Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy.

Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, Tanner JE, Sayers TJ, Seki N, Okumura K, Yagita H, Smyth MJ. Takeda K, et al. Among authors: okumura k. J Exp Med. 2004 Feb 16;199(4):437-48. doi: 10.1084/jem.20031457. Epub 2004 Feb 9. J Exp Med. 2004. PMID: 14769851 Free PMC article.

9

Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes.

Jin L, Nakao A, Nakayama M, Yamaguchi N, Kojima Y, Nakano N, Tsuboi R, Okumura K, Yagita H, Ogawa H. Jin L, et al. Among authors: okumura k. J Invest Dermatol. 2004 May;122(5):1175-9. doi: 10.1111/j.0022-202X.2004.22419.x. J Invest Dermatol. 2004. PMID: 15140220 Free article.

10

TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.

Kaduka Y, Takeda K, Nakayama M, Kinoshita K, Yagita H, Okumura K. Kaduka Y, et al. Among authors: okumura k. Biochem Biophys Res Commun. 2005 Jun 3;331(2):384-90. doi: 10.1016/j.bbrc.2005.03.176. Biochem Biophys Res Commun. 2005. PMID: 15850771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,038 results

Search Page

Filters